Highlights Oxford BioDynamics Plc

Equities

OBD

GB00BD5H8572

Market Closed - London S.E. Other stock markets 11:35:27 2024-04-26 am EDT			5-day change	1st Jan Change
8.1 ^GBX	-1.22%		-9.90%	-71.07%

Apr. 03	Oxford BioDynamics reaches "important milestone" with new laboratory	AN
Apr. 03	Oxford BioDynamics Plc Opens Clinical Testing Facility in the UK to Perform EpiSwitch Prostate Screening Blood Test	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oxford BioDynamics reaches "important milestone" with new laboratory	Apr. 03	AN
Oxford BioDynamics Plc Opens Clinical Testing Facility in the UK to Perform EpiSwitch Prostate Screening Blood Test	Apr. 03	CI
FireAngel CFO resigns; ECR Minerals raises GBP585,000	Mar. 14	AN
EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal	Mar. 13	AN
Oxford BioDynamics plunges as annual loss widens; revenue up	Jan. 17	AN
Oxford BioDynamics plunge as annual profit rises; revenue up	Jan. 17	AN
Oxford BioDynamics shares plunge as annual revenue widens; revenue up	Jan. 17	AN
AIM WINNERS & LOSERS: James Cropper falls on lower outlook	Jan. 17	AN
Earnings Flash (OBD.L) OXFORD BIODYNAMICS Reports FY23 Revenue GBP510,000	Jan. 17	MT
Earnings Flash (OBD.L) OXFORD BIODYNAMICS Reports FY23 Loss GBX-7.30	Jan. 17	MT
Oxford BioDynamics Plc Reports Earnings Results for the Full Year Ended September 30, 2023	Jan. 17	CI
Oxford BioDynamics Strikes Deal with Bupa for Access to Blood Test	23-10-18	MT
Oxford BioDynamics in deal with Bupa to expand blood test access	23-10-18	AN
Oxford BioDynamics, Plc Announces a Strategic Agreement to Give Bupa Patients Access to OBD'sEpiSwitch CiRT	23-10-18	CI
Oxford Biodynamics Surges 92% With Early Launch of Prostate Screening Test	23-09-26	MT
Oxford BioDynamics Plc Launches 94% Accurate PSE Test in US and UK	23-09-26	CI
Oxford BioDynamics Plc Announces Validation of Its Episwitch Prostate Screening Test in Its US Clinical (CLIA-Certified) Laboratory Is Now Complete, Ahead of Schedule	23-09-26	CI
Oxford BioDynamics half-year loss widens; outlook remains uncertain	23-05-30	AN
Earnings Flash (OBD.L) OXFORD BIODYNAMICS Reports Fiscal H1 Revenue GBP220,000	23-05-30	MT
Earnings Flash (OBD.L) OXFORD BIODYNAMICS Reports Fiscal H1 Loss GBX-3.20	23-05-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Oxford BioDynamics Plc

Equities

OBD

GB00BD5H8572

Highlights

Filters